HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of May 21, 2026, HSCS trades at $1.99 with a market cap of $5.92M and a P/E ratio of -0.40. HSCS moved +0.00% today. Year to date, HSCS is -37.34%; over the trailing twelve months it is -57.02%. Its 52-week range spans $1.77 to $6.47. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own HSCS include Citadel Advisors and Two Sigma. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HeartSciences Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $1.99 |
| Market Cap | $5.92M |
| P/E Ratio | -0.40 |
| EPS | $-4.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.47 |
| 52-Week Low | $1.77 |
| Volume | 145 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.67K |
| Net Income | $-8.49M |
| Gross Margin | 57.92% |
2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.